Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacokinetic interactions between omeprazole/pantoprazole and clarithromycin in health volunteers.

Pharmacological research - 1 May 2004

Calabresi Laura, Pazzucconi Franco, Ferrara Stefano, Di Paolo Antonello, Tacca Mario Del, Sirtori Cesare

Abstract excerpt

The association omeprazole/clarithromycin is of current wide use in the treatment of Helicobacter pylori associated gastroduodenal ulcer. This combination may result in increased levels of omeprazole with potential interactions with commonly associated drugs. Kinetic/metabolic changes occurring after omeprazole/clarithromycin were compared to those occurring after pantoprazole/clarithromycin in healthy...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 2-Pyridinylmethylsulfinylbenzimidazoles
Share to Clarithromycin

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cross-Over Studies

Share to Half-Life

Share to Metabolic Clearance Rate

Share to Omeprazole

Share to Proton Pump Inhibitors

Share to Proton Pumps

Source

Identifiers

PMID: 14998561
DOI: 10.1016/j.phrs.2003.10.010

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacokinetic interactions between omeprazole/pantoprazole and clarithromycin in health volunteers.PMID 14998561Read ↗

Effects of clarithromycin on the metabolism of omeprazole in relation to CYP2C19 genotype status in humans.Semantic proximity Read ↗

CYP2C19 genotypes and omeprazole metabolism after single and repeated dosing when combined with clarithromycin.Semantic proximity Read ↗

Effects of clarithromycin on lansoprazole pharmacokinetics between CYP2C19 genotypes.Semantic proximity Read ↗

Comparison of the kinetic disposition of and serum gastrin change by lansoprazole versus rabeprazole during an 8-day dosing scheme in relation to CYP2C19 polymorphism.Semantic proximity Read ↗

Optimal dose of omeprazole for CYP2C19 extensive metabolizers in anti-Helicobacter pylori therapy: pharmacokinetic considerations.Semantic proximity Read ↗

Phenocopies of poor metabolizers of omeprazole caused by liver disease and drug treatment.Semantic proximity Read ↗

Pharmacokinetics of pantoprazole in man.Semantic proximity Read ↗

CYP2C19 polymorphism affects single-dose pharmacokinetics of oral pantoprazole in healthy volunteers.Semantic proximity Read ↗

The role of cytochrome P2C19 in R-warfarin pharmacokinetics and its interaction with omeprazole.Semantic proximity Read ↗

Rate of onset of inhibition of gut-wall and hepatic CYP3A by clarithromycin.Semantic proximity Read ↗

Effect of food on the pharmacokinetics of omeprazole, pantoprazole and rabeprazole.Semantic proximity Read ↗

Gefitinib-phenytoin interaction is not correlated with the C-erythromycin breath test in healthy male volunteers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.